End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.38 CNY | -0.62% |
|
-0.35% | -21.16% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 68% by 2026.
- With a P/E ratio at 11.6 for the current year and 9.4 for next year, earnings multiples are highly attractive compared with competitors.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-21.16% | 410M | C- | ||
+18.91% | 67.29B | A- | ||
-6.54% | 45.32B | A- | ||
+23.68% | 43.72B | B+ | ||
+37.91% | 28.07B | A- | ||
+9.03% | 19.24B | C+ | ||
+15.11% | 17.22B | B+ | ||
-26.04% | 14.64B | A- | ||
-13.27% | 14.51B | B+ | ||
-29.84% | 11.58B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 603217 Stock
- Ratings Yuanli Chemical Group Co.,Ltd.